Transaction · 0001062822-26-000031

DEBBANE RAYMOND

DEBBANE RAYMOND, DIR, reported an open-market or private purchase at LEXICON PHARMACEUTICALS, INC. involving 100000.000000 shares for an estimated $147790.00. Reported holdings after the transaction were 1804186.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
LXRXLEXICON PHARMACEUTICALS, INC.
Filing timeFeb 23
Trade dateFeb 20, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.51
Pre-filing
1mo ago +3.3%1w ago -13.2%1d ago +0.7%
Returns since
7d +3.3%30d +11.3%90d +43.0%180d +51.7%1y +55.0%

LXRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
LXRX since 2026-02-23Filed 192 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001062822-26-000031
Common Stock
Transaction date
Feb 20, 2026
Filed Feb 23, 2026, 12:00 AM · 3d delay
Shares
100k sh
$148 per share
Estimated value
$14.7M
Computed from shares × price
Holdings after
1.80M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Director Buy Direct Ownership Repeat Buyer
+32score
Filing-only score

+32

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.425 to $1.455 per share. The reporting person hereby undertakes to provide to the is…

  2. F2

    Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.49 per share. The reporting person hereby undertakes to provide to the issu…

Original filing · 0001062822-26-000031
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

LXRX